These findings suggest that negative modulation of CHCHD2 through shRNA knockdown enhances oxidative stress-induced apoptosis, highlighting the essential role of CHCHD2 in modulation of ROS levels and cellular protection against oxidative stress in both WT and HD cells. Here, CHCHD2 is linked to Huntington disease.